Contact us   |  

ERN-EuroBloodNet webinars for health professionals will continue in September!

ERN-EuroBloodNet webinars for health professionals will continue in September!

2021-08-03
ERN-EuroBloodNet webinars for health professionals will continue in September!

After the summer break, four webinar programs will resume. Have a look at the program!

ERN-EuroBloodNet invests a lot in online education because this has a great impact on disseminating cutting-edge knowledge on rare hematological diseases. Session's speakers are provided by experts in the field. Furthermore, those online programs allow a great interaction with the audience because questions are gathered in real-time in the dedicated Q&A sessions, after the speech.

Recorded sessions are then also available on EuroBloodNet's website and EuroBloodNet's EDU YouTube channel and the PowerPoint presentation downloadable.

Please, find the list of the programs that will resume in September:

ERN-EuroBloodNet Thursday webinars for Health Professionals

The aim of these educational activities is promoting the interest on very innovative topics in order to stress among health professionals the cutting-edge advances in the field of Rare Hematological Diseases. Webinars are mainly addressed on very rare diseases, complex disorders, highly specialized procedures and implementation of guidelines. At the same time, webinars' programs that are specifically addressed to patients intends to increase the awareness on a specific rare hematological disease among patients' advocates and patients associations.

ERN-EuroBloodNet Topic on Focus on Thrombotic Microangiopathies for Health Professionals

This program has been developed in collaboration with the French reference center for thrombotic microangiopathies (CNR-MAT). Fifteen webinars divided into two chapters are led by experts in the field of Thrombotic Microangiopathies and have a form of PowerPoint presentations. The main objective of this program is to disseminate very innovative topics among hematologists, internists, nephrologists, pediatricians, or other health care providers interested in the topic in order to give visibility to the last cutting-edge advances in the field of Thrombotic Microangiopathies (TMAs).

Hemolytic uremic syndrome and other thrombotic microangiopathies: